Release time：2023-10-12
On June 29-30, 2023, the 9th China Biomedical Innovation Cooperation Conference (BIO-PHARM2023) and the 2023 China Biomedical Industry Value List Award Ceremony were held at Kempinski Hotel Jinji Lake in Suzhou. The conference invited more than 200 industry leaders and more than 1,800 expert audiences to carry out two-day forums in the form of keynote speeches, roundtable discussions, private seminars, one-on-one business negotiations, list releases, award dinners, poster displays, etc., and carry out all-round and multi-level academic exchange activities.
Academician Guan Guoliang, Chairman of Changzhou Trendi Medical Technology Co., Ltd., attended the event as a guest and delivered a keynote speech on "Medical Technology of Personalized Drugs for Epilepsy and Other Diseases" at the opening ceremony. During the speech, Academician Guan Guoliang freely switched between Chinese and English, and introduced to the participants the latest scientific research achievements made by his team in the field of epilepsy treatment and the personalized epilepsy treatment management platform technology developed by Advance Medical, and his cutting-edge vision and innovative technology were warmly applauded by the audience.
The conference pointed out that biomedicine, as an industry with large investment and long cycle, especially needs the support and cultivation of government policies, the long-term adherence of enterprises and scientists, and the multi-channel opening up of upstream and downstream industrial chains to comprehensively empower industrial development.
Since its establishment, Changzhou Trendi Medical Technology Co., Ltd. has always taken "introducing the old and innovating" as its business philosophy, constantly exploring new products and services, and welcoming all partners with an open attitude. In the future, Advance Medical will also actively promote cooperation with multiple parties, build an industry ecosystem, transform advanced innovative technologies into high-quality products and services, and contribute to the development of the biomedical field.
